Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vitalitec International is a medical device company focused on surgical products rather than a drug-development biotech or pharmaceutical pipeline. Publicly available sources indicate the business has developed, manufactured, and marketed niche vascular, cardiovascular, endoscopic, laparoscopic, arthroscopy, and general surgical instruments, with strengths in specialty instrumentation and vessel occlusion products. The company appears to have operated through both a U.S. entity and a German manufacturing/distribution entity. Vitalitec International was acquired by Groupe Péters Surgical in March 2014, and a subsequent merger between Péters Surgical and Vitalitec International was finalized on June 1, 2016. Despite the acquisition history, the German Vitalitec website remains online and describes the company as an independent manufacturer, distributor, and service provider, so the corporate identity appears historically acquired but with at least some ongoing brand or operating presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vitalitec International.